Diagnosis of Underlying Disease in Men with Erectile Dysfunction Receiving Phosphodiesterase Type 5 Inhibitors in the United Kingdom

Mar-09

Men's Health Pharmacoepidemiology Urology

AUTHORS : Prof Michael Kirby, Faculty of Health and Human Sciences, University of Hertfordshire, Hatfield, Hertfordshire, AL10 9AB – Email: kirbym@globalnet.co.uk – Profile: https://researchprofiles.herts.ac.uk/portal/en/persons/michael-kirby(ed3051f0-e4f7-484d-bd77-e3c40bfd8219).html AND http://www.pctag.uk/2016/08/dr-mike-kirby-frcp/

JOURNAL : European Urology Supplements

REFERENCE: 8(4):172

DOI : 10.1016/S1569-9056(09)60213-X

Diagnosis of Underlying Disease in Men with Erectile Dysfunction Receiving Phosphodiesterase Type 5 Inhibitors in the United Kingdom

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study